Verrills NM - Search Results

1

Clinical proteomics: present and future prospects.

Verrills NM. Verrills NM. Clin Biochem Rev. 2006 May;27(2):99-116. Clin Biochem Rev. 2006. PMID: 17077880 Free PMC article.

2

Drug resistance mechanisms in cancer cells: a proteomics perspective.

Verrills NM, Kavallaris M. Verrills NM, et al. Curr Opin Mol Ther. 2003 Jun;5(3):258-65. Curr Opin Mol Ther. 2003. PMID: 12870435 Review.

3

Harnessing the power of proteomics for identification of oncogenic, druggable signalling pathways in cancer.

Murray HC, Dun MD, Verrills NM. Murray HC, et al. Among authors: verrills nm. Expert Opin Drug Discov. 2017 May;12(5):431-447. doi: 10.1080/17460441.2017.1304377. Epub 2017 Mar 17. Expert Opin Drug Discov. 2017. PMID: 28286965 Review.

4

Cell-Free DNA Blood Collection Tubes Are Appropriate for Clinical Proteomics: A Demonstration in Colorectal Cancer.

Almazi JG, Pockney P, Gedye C, Smith ND, Hondermarck H, Verrills NM, Dun MD. Almazi JG, et al. Among authors: verrills nm. Proteomics Clin Appl. 2018 May;12(3):e1700121. doi: 10.1002/prca.201700121. Epub 2018 Mar 30. Proteomics Clin Appl. 2018. PMID: 29476593 Free PMC article.

5

Improving the targeting of tubulin-binding agents: lessons from drug resistance studies.

Verrills NM, Kavallaris M. Verrills NM, et al. Curr Pharm Des. 2005;11(13):1719-33. doi: 10.2174/1381612053764706. Curr Pharm Des. 2005. PMID: 15892670 Review.

6

The proteomics of ageing.

Cobon GS, Verrills N, Papakostopoulos P, Eastwood H, Linnane AW. Cobon GS, et al. Biogerontology. 2002;3(1-2):133-6. doi: 10.1023/a:1015240304287. Biogerontology. 2002. PMID: 12014833

7

Mast cell function: regulation of degranulation by serine/threonine phosphatases.

Sim AT, Ludowyke RI, Verrills NM. Sim AT, et al. Among authors: verrills nm. Pharmacol Ther. 2006 Nov;112(2):425-39. doi: 10.1016/j.pharmthera.2006.04.011. Epub 2006 Jun 21. Pharmacol Ther. 2006. PMID: 16790278 Review.

8

Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia--an in vivo study.

Verrills NM, Liem NL, Liaw TY, Hood BD, Lock RB, Kavallaris M. Verrills NM, et al. Proteomics. 2006 Mar;6(5):1681-94. doi: 10.1002/pmic.200500417. Proteomics. 2006. PMID: 16456880

9

PR55α-containing protein phosphatase 2A complexes promote cancer cell migration and invasion through regulation of AP-1 transcriptional activity.

Gilan O, Diesch J, Amalia M, Jastrzebski K, Chueh AC, Verrills NM, Pearson RB, Mariadason JM, Tulchinsky E, Hannan RD, Dhillon AS. Gilan O, et al. Among authors: verrills nm. Oncogene. 2015 Mar 5;34(10):1333-9. doi: 10.1038/onc.2014.26. Epub 2014 Mar 17. Oncogene. 2015. PMID: 24632621

10

A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia.

Enjeti AK, D'Crus A, Melville K, Verrills NM, Rowlings P. Enjeti AK, et al. Among authors: verrills nm. Anticancer Drugs. 2016 Jul;27(6):560-8. doi: 10.1097/CAD.0000000000000358. Anticancer Drugs. 2016. PMID: 26967515 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results